Abstract
Thirty-seven cases of microbiologically demonstrated pyogenic hepatic abscess were observed in a prospective study over a seven-year period. Biliary disease was the most common source of liver abscess (42%).Streptococcus milleri was the most common cause of hepatic abscess, accounting for 51% of the cases. Hepatic abscess is due toStreptococcus milleri clinically distinct from other forms of pyogenic liver abscess due to its torpid nature and the longer duration of its symptoms [42 vs. 11 days]. Occult hepatic abscess should be suspected if the blood culture is positive forStreptococcus milleri, since 28% of bacteremia cases due toStreptococcus milleri stem from hepatic abscesses. It is important to distinguishStreptococcus milleri from other members of the viridans streptococci group, which are frequently isolated as contaminants, but only exceptionally cause hepatic abscess. Unlike other pyogenic hepatic abscesses, those caused byStreptococcus milleri are frequently monomicrobial (79%). In the present study, empirical therapy of pyogenic hepatic abscess always included a drug that is effective againstStreptococcus milleri.
Similar content being viewed by others
References
Ochsner A, DeBakey M, Murray S: Pyogenic abscess of the liver: an analysis of forty-seven cases with review of the literature. American Journal of Surgery (1938) 40:292–319
Sherman J, Robbins S: Changing trends in the casuistics of hepatic abscess. American Journal of Medicine (1960) 28:943–950
Rubin RH, Swartz MN, Malt R: Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects. American Journal of Medicine (1974) 57:601–610
Altemeier WA: Recent trends in management of hepatic abscess. Delaware Medical Journal (1971) 43:327–336
Lee J, Block G: The changing clinical pattern of hepatic abscesses. Archives of Surgery (1972) 104:465–470
Pitt H, Zuidema G: Factors influencing mortality in the treatment of pyogenic hepatic abscess. Surgery, Gynecology & Obstetrics (1975) 140:228–234
Miedema B, Dineen P: The diagnosis and treatment of pyogenic liver abscesses. Annals of Surgery (1984) 200:328–334
McDonald M, Corey R, Gallis H, Durack D: Single and multiple pyogenic liver abscesses. Natural history, diagnosis and treatment, with emphasis on percutaneous drainage. Medicine (1981) 63:291–302
Branun G, Tyson G, Branun M, Meyers W: Hepatic abscess. Changes in etiology, diagnosis and management. Annals of Surgery (1990) 212:655–662
Corbella X, Vadillo M, Torras J, Pujol M, Rafecas A, Gudiol F: Presentación, diagnóstico y tratamiento del absceso hepático piógeno: analisis de una serie de 63 casos. Enfermedades Infecciosas y Microbiología Clínica (1995) 13:80–84
Seeto R, Rockey D: Pyogenic liver abscess. Changes in etiology, management and outcome. Medicine (1996) 75:99–113
Chu K, Fan S, Lai E, Lo C, Wong J: Pyogenic liver abscess. An audit of experience over the past decade. Archives of Surgery (1996) 131:148–152
Duma R, Weinberg A, Medrek T, Kun L: Streptococcal infections. Medicine (1969) 48:87–127
Parker MT, Ball LC: Streptococci and aerococci associated with systemic infection in man. Journal of Medical Microbiology (1976) 9:275–302
Facklam RR: Physiological differentiation of viridans streptococci. Journal of Clinical Microbiology (1977) 5:184–201
Murray H, Gross K, Masur H, Roberts R: Serious infections caused byStreptococcus milleri. American Journal of Medicine (1978) 64:759–764
Bateman NT, Eykyn SJ, Phillips I: Pyogenic liver abscess caused byStreptococcus milleri. Lancet (1975) 1:657–659
Moore-Gillon JC, Eykyn S, Phillips I: Microbiology of pyogenic liver abscess. British Medical Journal (1981) 283:819–821
Whiley RA, Beighton D: Emended descriptions and recognition ofStreptococcus constellatus, Streptococcus intermedius, andStreptococcus anginosus as distinct species. International Journal of Systematic Bacteriology (1991) 41:1–5
Reid TM, Davidson AI:Streptococcus milleri liver abscesses. Lancet (1976) 2: 648–649
Allison HF, Immelman EJ, Forder AA: Pyogenic liver abscess caused byStreptococcus milleri. case reports. South African Medical Journal (1984) 65:432–435
Henderson A, Wall D:Streptococcus milleri liver abscess presenting as fulminant pneumonia. Australian and New Zealand Journal of Surgery (1993) 63:237–240
De Mestier P, Guez C, Chakkour K, Khayat M, Chevalier T: Abces hepatique aStreptococcus milleri. Gastroenterologie Clinique et Biologique (1992) 16:1007–1008
Risi GF: Additional case of liver abscess due toStreptococcus milleri. Reviews of Infectious Diseases (1989) 11:837–838
Gelfand MS, Hodgkiss T, Simmons BP: Multiple hepatic abscesses caused byStreptococcus milleri in association with an intrauterine device. Reviews of Infectious Diseases (1989) 11: 983–987
Brasitus TA, Cleri DJ, Szabo K:Streptococcus MG-intermedius [Streptococcus milleri] hepatic abscess in two patients with regional enteritis. Southern Medical Journal (1983) 76:1297–1298
Hatoff DE: Perineal Crohn's disease complicated by pyogenic liver abscess during metronidazole therapy. Gastroenterology (1983) 85:194–195
Chua D, Reinhart H, Sobel J: Liver abscess caused byStreptococcus milleri. Reviews of Infectious Diseases (1989) 11:197–202
Bauer AN, Kirby WM, Sherris JC, Furck M: Antibiotic susceptibility testing by standarized single disc method. American Journal of Clinical Pathology (1966) 45:493–496
Casariego E, Rodrfguez A, Corredoira J, Alonso P, Coira A, Bal M, López MJ, Varela J: Prospective study ofStreptococcus milleri bacteremia. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:194–200
Whiley RA, Fraser H, Hardie JM, Beighton D: Phenotypic differentiation ofStreptococcus intermedius, Streptococcus constellatus, andStreptococcus anginosus strains within the “Streptococcus milleri group”. Journal of Clinical Microbiology (1990) 28:1497–1501
Gómez-Garcés JL, Alós J, Cogollos R: Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates ofStreptococcus milleri group. Diagnostic Microbiology and Infectious Disease (1994) 19:69–73
Salavert M, Gómez L, Rodríguez-Carballeira M, Xercavins M, Freixas N, Garau J: Seven-year review of bacteremia caused byStreptococcus milleri and other viridans streptococci. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15: 365–371
Gossling J: Occurrence and pathogenicity of theStreptococcus milleri group. Reviews of Infectious Diseases (1988) 10:257–285
Gerzof SG, Johnson WC, Robbins AH, Nabseth DC: Intrahepatic pyogenic abscesses: treatment by percutaneous drainage. American Journal of Surgery (1985) 149:487–494
Herbert DA, Rothman J, Simmons F, Fogel D, Wilson S, Ruskin J: Pyogenic liver abscesses: successful non-surgical therapy. Lancet (1982) i: 134–136
Berger LA, Osborne DR: Treatment of pyogenic liver abscesses by percutaneous needle aspiration. Lancet (1982) i: 132–134
Reynolds T: Medical treatment of pyogenic liver abscess. Annals of Internal Medicine (1982) 96:373–374
Levison M, Bush L: Peritonitis and other intra-abdominal infections. In: Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. Churchill Livingstone, New York (1995) pp. 705–739
Tresadern JC, Farrand RJ, Irving MH:Streptococcus milleri and surgical sepsis. Annals of the Royal College of Surgeons of England (1983) 65:78–79
Alcaide F, Liñares J, Pallarés R, Carratala J, Benitez MA, Gudiol F, Martín R: In vitro activities of 22β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrobial Agents and Chemotherapy (1995) 39:2243–2247
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Corredoira, J., Casariego, E., Moreno, C. et al. Prospective study ofStreptococcus milleri hepatic abscess. Eur. J. Clin. Microbiol. Infect. Dis. 17, 556–560 (1998). https://doi.org/10.1007/BF01708618
Issue Date:
DOI: https://doi.org/10.1007/BF01708618